These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 17204960
1. Long-term therapeutic efficacy of lamivudine compared with interferon-alpha in children with chronic hepatitis B: the younger the better. Choe BH, Lee JH, Jang YC, Jang CH, Oh KW, Kwon S, Hyun MC, Ko CW, Lee KS, Lee WK. J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):92-8. PubMed ID: 17204960 [Abstract] [Full Text] [Related]
2. [Comparison of lamivudine-induced HBsAg loss rate according to age in children with chronic hepatitis B]. Kim JM, Choe BH, Chu MA, Cho SM. Korean J Hepatol; 2009 Jun; 15(2):168-78. PubMed ID: 19581769 [Abstract] [Full Text] [Related]
6. Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety. Jonas MM, Little NR, Gardner SD, International Pediatric Lamivudine Investigator Group. J Viral Hepat; 2008 Jan; 15(1):20-7. PubMed ID: 18088241 [Abstract] [Full Text] [Related]
8. Economic evaluation of lamivudine compared with interferon-alpha in the treatment of chronic hepatitis B in the United States. Brooks EA, Lacey LF, Payne SL, Miller DW. Am J Manag Care; 2001 Jul; 7(7):677-82. PubMed ID: 11464426 [Abstract] [Full Text] [Related]
9. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B. Wong VW, Wong GL, Tsang SW, Hui AY, Chim AM, Yiu KK, Chan HY, Chan FK, Sung JJ, Chan HL. Antivir Ther; 2008 Jul; 13(4):571-9. PubMed ID: 18672536 [Abstract] [Full Text] [Related]
10. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B. Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kawamura Y, Kobayashi M, Kumada H. J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775 [Abstract] [Full Text] [Related]
13. [Comparison of different combination therapies for children with HBeAg positive chronic hepatitis B]. Zhong XH, Deng X, Chen XC, Zhou BP. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):62-3. PubMed ID: 17429539 [Abstract] [Full Text] [Related]
14. Combined lamivudine/interferon-alpha treatment in "immunotolerant" children perinatally infected with hepatitis B: a pilot study. D'Antiga L, Aw M, Atkins M, Moorat A, Vergani D, Mieli-Vergani G. J Pediatr; 2006 Feb; 148(2):228-233. PubMed ID: 16492434 [Abstract] [Full Text] [Related]
15. Treatment of children persistently infected with hepatitis B virus: seroconversion or suppression. Price N, Boxall EH. J Antimicrob Chemother; 2007 Dec; 60(6):1189-92. PubMed ID: 17913721 [Abstract] [Full Text] [Related]
17. Efficacy of combined interferon alpha and long-term lamivudine therapy in children with chronic hepatitis B. Kuloğlu Z, Kansu A, Erden E, Girgin N. Turk J Pediatr; 2010 Dec; 52(5):457-63. PubMed ID: 21434529 [Abstract] [Full Text] [Related]
18. Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine. Kobayashi M, Suzuki F, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Yatsuji H, Kobayashi M, Suzuki Y, Arase Y, Ikeda K, Watahiki S, Iwasaki S, Miyakawa Y, Kumada H. J Med Virol; 2007 Oct; 79(10):1472-7. PubMed ID: 17705186 [Abstract] [Full Text] [Related]